Atea Pharmaceuticals's total assets for Q2 2025 were $391.61M, a decrease of -10.99% from the previous quarter. AVIR total liabilities were $27.19M for the fiscal quarter, a -5.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.